世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000043024

2025〜2030年のスペインの分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

VPGMarketResearch

2025-2030 Spain Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

発刊日 2025/11/15

言語英語

体裁PDF

ライセンス/価格

0000043024

Local PDF
Global PDF

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

LeadingMarketResearch.com のこのデータベースは、感染症、遺伝性疾患、がん診断、法医学および親子鑑定アプリケーションに関する2024年のサプライヤーシェア、2024 〜 2028年の数量と売上予測、および主要な検査用の新技術や製品を開発または販売している企業の包括的なリストを提供します。

主要企業

  • Abbott
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Cepheid/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Decode Genetics
  • Diasorin
  • 栄研化学(Eiken Chemical)
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ(Fujirebio)
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • LabCorp/Sequenom
  • Leica Biosystems/Kreatech
  • Li-Cor Biosciences
  • Myriad Genetics
  • Proteome Sciences
  • Qiagen
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • 島津製作所(Shimadzu)
  • Siemens Healthineers
  • タカラバイオ(Takara Bio)
  • Tecan Group
  • Thermo Fisher

レポート詳細

図表

List of Tables
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases
Spain
Molecular Diagnostics Test Volume And Sales
By Major Application
Spain
Laboratories Performing DNA Sequencing
By Market Segment
Spain
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Spain
Molecular Diagnostics Test Volume
By Major Application
Spain
Major Infectious Disease Test Volume by Assay
Spain
Major Infectious Disease Test Volume by Method
Spain
Molecular Diagnostics Market
By Major Application
Spain
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
Spain
Major Infectious Disease Diagnostics Market by Assay
Spain
AIDS Testing Market
Estimated Sales by Major Supplier
Spain
Chlamydia Testing Market
Estimated Sales by Major Supplier
Spain
CMV Testing Market
Estimated Sales by Major Supplier
Spain
Gonorrhea Testing Market
Estimated Sales by Major Supplier
Spain
Hepatitis Testing Market
Estimated Sales by Major Supplier
Spain
Hepatitis C Testing Market
Estimated Sales by Major Supplier
Spain
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier
Spain
Herpes Testing Market
Estimated Sales by Major Supplier
Spain
Influenza Testing Market
Estimated Sales by Major Supplier
Spain
Meningitis Testing Market
Estimated Sales by Major Supplier
Spain
Mycoplasma Testing Market
Estimated Sales by Major Supplier

この商品のレポートナンバー

0000043024

最近見たレポート

2025〜2030年のドイツの分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

2025-2030 Germany Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2025/11/15

1,500 USD

2025〜2030年のフランスの分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

2025-2030 France Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2025/11/15

1,500 USD

2025〜2030年のヨーロッパの分子診断市場(38カ国):2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

2025-2030 Europe Molecular Diagnostics Market in 38 Countries: 2025 Supplier Shares, Analyzer Installed Base and Strategies by Country, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

2025/11/15

13,500 USD

世界の神経内視鏡デバイス市場の規模、トレンド、機会分析レポート - 製品別(硬性、軟性)、用途別(経鼻、脳室内、経頭蓋)、ユーザビリティ別(再利用可能、使い捨て)、最終用途別(病院、外来施設)、および予測(2024〜2035年)

Global Neuroendoscopy Devices Market Size, Trend & Opportunity Analysis Report, by Product (Rigid, Flexible), Application (Transnasal, Intraventricular, Transcranial), Usability (Reusable, Disposable), End Use (Hospitals, Outpatient Facilities), and Forecast, 2024-2035

2025/10/22

2,950 USD

ヘルスケアにおける4Dプリンティングの世界市場規模調査と予測:コンポーネント別(機器、3DプリンターSMM、ハイドロゲル、ソフトウェア、サービス、セル)、技術別(FDM、SLS、ステレオリソグラフィー)、用途別(研究モデル、インプラント)、および地域別予測(2025年〜2035年)

Global 4D Printing in Healthcare Market Size Study & Forecast, by Component (Equipment, 3D Printer SMM, Hydrogels, Software, Service, Cells), Technology (FDM, SLS, Stereolithography) and Application (Research Model, Implant) and Regional Forecasts 2025-2035

2025/12/02

4,950 USD

世界の子宮内避妊器具市場規模調査と予測:タイプ別(ホルモン性IUDおよび銅製IUD)、流通チャネル別(病院および婦人科クリニック)、地域別予測(2025〜2035年)

Global Intrauterine Devices Market Size Study & Forecast, by Type (Hormonal IUD and Copper IUD) by Distribution Channel (Hospital and Gynecology Clinics) and Regional Forecasts 2025-2035

2025/12/02

4,950 USD

TOP